Third Harmonic Bio Inc (THRD)

Feb 01, 2025

Soho House, Third Harmonic Bio, and More Stocks See Action From Activist Investors - MSN

Feb 01, 2025

Jan 28, 2025

Where are the Opportunities in (THRD) - Stock Traders Daily

Jan 28, 2025

Jan 28, 2025

Third Harmonic Bio stock hits 52-week low at $5.58 - MSN

Jan 28, 2025

Jan 23, 2025

Haoxi Health Technology announces 1-for-25 reverse share split; shares plummet - MSN

Jan 23, 2025

Jan 22, 2025

GENERAL ATLANTIC, L.P. Acquires Additional Shares in Third Harmo - GuruFocus.com

Jan 22, 2025

Jan 21, 2025

Sionna, Odyssey join queue of biotechs testing investors’ IPO interest - BioPharma Dive

Jan 21, 2025

Jan 18, 2025

Trend Tracker for (THRD) - Stock Traders Daily

Jan 18, 2025

Jan 17, 2025

Papaya Growth Opportunity Stock Hits All-Time High of $12.5 - MSN

Jan 17, 2025

Jan 14, 2025

Jefferies cuts Third Harmonic stock target to $7 from $15 By Investing.com - Investing.com Canada

Jan 14, 2025

Jan 13, 2025

Third Harmonic Bio shares drop to lowest since 2023 By Investing.com - Investing.com Canada

Jan 13, 2025

Jan 10, 2025

Third Harmonic Bio stock hits 52-week low at $8.04 - Investing.com India

Jan 10, 2025

Jan 09, 2025

Dermata Therapeutics Inc (DRMA): Major Improvements, Worth A Look - Stocks Register

Jan 09, 2025

Jan 08, 2025

Stifel maintains positive outlook on Celldex and Third Harmonic stocks By Investing.com - Investing.com Canada

Jan 08, 2025

Jan 08, 2025

Revance gains as it plans to enter talks with Teoxane on likely superior bid (RVNC:NASDAQ) - Seeking Alpha

Jan 08, 2025

Jan 07, 2025

Learn to Evaluate (THRD) using the Charts - Stock Traders Daily

Jan 07, 2025

Jan 07, 2025

Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews

Jan 07, 2025

Jan 06, 2025

Revance Therapeutics jumps after Teoxane offers $3.60 a share (NASDAQ:RVNC) - Seeking Alpha

Jan 06, 2025

Jan 03, 2025

Eton acquires Wilson disease drug Galzin (ETON:NASDAQ) - Seeking Alpha

Jan 03, 2025

Jan 02, 2025

Neumora stock drops on depression trial failure (NMRA:NASDAQ) - Seeking Alpha

Jan 02, 2025

Dec 28, 2024

Trading (THRD) With Integrated Risk Controls - Stock Traders Daily

Dec 28, 2024

Dec 19, 2024

Aquestive receives FDA Orphan Drug Exclusivity for Libervant - Seeking Alpha

Dec 19, 2024

Dec 17, 2024

Long Term Trading Analysis for (THRD) - Stock Traders Daily

Dec 17, 2024

Dec 17, 2024

Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com Australia

Dec 17, 2024

Dec 10, 2024

Third Harmonic Bio's SWOT analysis: stock outlook brightens on clinical progress - Investing.com India

Dec 10, 2024

Dec 10, 2024

Stock Market Analysis & Tools for Investors - Seeking Alpha

Dec 10, 2024

Dec 10, 2024

Third Harmonic Bio's SWOT analysis: stock outlook brightens on clinical progress By Investing.com - Investing.com South Africa

Dec 10, 2024

Dec 09, 2024

Dimension gets $500M to bankroll biotech’s convergence with tech - BioPharma Dive

Dec 09, 2024

Dec 05, 2024

Atlas Venture Announces $450 Million Fund XIV - Yahoo Finance

Dec 05, 2024

Nov 26, 2024

How the (THRD) price action is used to our Advantage - Stock Traders Daily

Nov 26, 2024

Nov 25, 2024

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Marketscreener.com

Nov 25, 2024

Nov 25, 2024

Third Harmonic Bio to Present at Evercore HealthCONx Conference in December | THRD Stock News - StockTitan

Nov 25, 2024

Nov 20, 2024

Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade - MSN

Nov 20, 2024

Nov 19, 2024

Aclaris stock soars for second day on licensing deal, analyst upgrades (NASDAQ:ACRS) - Seeking Alpha

Nov 19, 2024

Nov 18, 2024

Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise (NASDAQ:AMLX) - Seeking Alpha

Nov 18, 2024

Nov 15, 2024

(THRD) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

RA Capital Management Reduces Stake in Third Harmonic Bio Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Significant Stake Increase by T. Rowe Price in Third Harmonic Bi - GuruFocus.com

Nov 14, 2024

Nov 12, 2024

Revance Therapeutics jumps after Crown Laboratories tender offer extended again - Seeking Alpha

Nov 12, 2024

Nov 11, 2024

Vertiv Rises 13% in a Month: Time for Investors to Buy the Stock? - MSN

Nov 11, 2024

Nov 11, 2024

Shiba Inu (SHIB) Price Rises 53% but Hits Rejection at Key Ascending Resistance Level - MSN

Nov 11, 2024

Nov 08, 2024

Canopy Growth stock on watch after Q2 results (CGC:NASDAQ) - Seeking Alpha

Nov 08, 2024

Nov 08, 2024

Third Harmonic Bio Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Third Harmonic Bio Inc (THRD) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Third Harmonic Bio (THRD) to Present at Major Stifel, Jefferies Healthcare Conferences | THRD Stock News - StockTitan

Nov 07, 2024

Nov 07, 2024

Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release

Nov 07, 2024

Nov 07, 2024

Third Harmonic Flat on Q3 Results - Baystreet.ca

Nov 07, 2024

Nov 07, 2024

Third Harmonic Bio Announces Third Quarter 2024 Financial Results - The Manila Times

Nov 07, 2024

Nov 07, 2024

Third Harmonic Bio Reports $296M Cash Position, Phase 1 Trial Progress Despite Wider Q3 Loss | THRD Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

An RNAi renaissance is creating a new generation of startups - BioPharma Dive

Nov 06, 2024

Nov 04, 2024

(THRD) Technical Data - Stock Traders Daily

Nov 04, 2024

Nov 01, 2024

Third harmonic bio sees $14.3 million in stock sales by BVF Partners - Investing.com India

Nov 01, 2024